264 related articles for article (PubMed ID: 23001328)
21. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
[TBL] [Abstract][Full Text] [Related]
22. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors.
Mentzel T; Dry S; Katenkamp D; Fletcher CD
Am J Surg Pathol; 1998 Oct; 22(10):1228-38. PubMed ID: 9777985
[TBL] [Abstract][Full Text] [Related]
23. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
[TBL] [Abstract][Full Text] [Related]
24. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
[TBL] [Abstract][Full Text] [Related]
25. Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features.
Mertens F; Romeo S; Bovée JV; Tirabosco R; Athanasou N; Alberghini M; Hogendoorn PC; Dei Tos AP; Sciot R; Domanski HA; Aström K; Mandahl N; Debiec-Rychter M
Clin Sarcoma Res; 2011 Oct; 1(1):10. PubMed ID: 22588017
[TBL] [Abstract][Full Text] [Related]
26. Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma.
Mentzel T; Calonje E; Fletcher CD
Am J Surg Pathol; 1994 Mar; 18(3):258-65. PubMed ID: 8116793
[TBL] [Abstract][Full Text] [Related]
27. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
[TBL] [Abstract][Full Text] [Related]
29. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
30. Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases.
Velazquez EF; Melamed J; Barreto JE; Aguero F; Cubilla AL
Am J Surg Pathol; 2005 Sep; 29(9):1152-8. PubMed ID: 16096403
[TBL] [Abstract][Full Text] [Related]
31. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
[TBL] [Abstract][Full Text] [Related]
32. Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years. A clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytoma-like osteosarcoma.
Naka T; Fukuda T; Shinohara N; Iwamoto Y; Sugioka Y; Tsuneyoshi M
Cancer; 1995 Sep; 76(6):972-84. PubMed ID: 8625223
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.
Tsuda Y; Dickson BC; Dry SM; Federman N; Suurmeijer AJH; Swanson D; Sung YS; Zhang L; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Apr; 59(4):217-224. PubMed ID: 31675134
[TBL] [Abstract][Full Text] [Related]
34. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma.
Meis-Kindblom JM; Kindblom LG; Enzinger FM
Am J Surg Pathol; 1995 Sep; 19(9):979-93. PubMed ID: 7661286
[TBL] [Abstract][Full Text] [Related]
35. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
36. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
37. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall.
Doyle LA; Fletcher CD
J Cutan Pathol; 2011 Sep; 38(9):697-703. PubMed ID: 21752057
[TBL] [Abstract][Full Text] [Related]
38. Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases.
Suster DI; Gross JM; Fayad L; Wenokor C; Goldsmith JD; Ward A; Early C; Lazano-Calderon S; Klein MJ
Skeletal Radiol; 2024 Feb; 53(2):387-393. PubMed ID: 37524934
[TBL] [Abstract][Full Text] [Related]
39. Atypical fibroxanthoma-a diagnosis of exclusion!
Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
[TBL] [Abstract][Full Text] [Related]
40. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
